CHD5 was recently identified as a novel tumor suppressor that maps to 1p36, which is frequently deleted in many types of human cancers [5], [6], and the chromatin-remodeling activity of CHD5 is required for appropriate transcriptional activation of the p19Arf/p53 pathway [7]. The gene discussed is CHD5; the disease is neoplasm.